Get the Stockscreener App
2.97
1.00%
-0.03
Alpha Tau Medical Ltd stock is traded at $2.97, with a volume of 1,628.
It is down -1.00% in the last 24 hours and up +16.02% over the past month.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
See More
Previous Close:
$3.00
Open:
$3
24h Volume:
1,628
Relative Volume:
0.04
Market Cap:
$250.71M
Revenue:
-
Net Income/Loss:
$-29.64M
P/E Ratio:
-6.907
EPS:
-0.43
Net Cash Flow:
$-39.43M
1W Performance:
-1.00%
1M Performance:
+16.02%
6M Performance:
+6.07%
1Y Performance:
+18.80%
1-Day Range:
$2.92
$3.0365
1-Week Range:
$2.92
$3.1199
52-Week Range:
$1.75
$4.3866
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Compare DRTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
2.96 | 254.10M | 0 | -29.64M | -39.43M | -0.43 |
|
ONC
Beone Medicines Ltd Adr
|
245.77 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.42 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.32 | 40.37M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
80.81 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.38 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-23 | Initiated | Citigroup | Buy |
| Apr-24-23 | Initiated | H.C. Wainwright | Buy |
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-22 | Initiated | Piper Sandler | Overweight |
| Apr-04-22 | Initiated | Citigroup | Buy |
Alpha Tau Medical Ltd Stock (DRTS) Latest News
Alpha Tau Medical to Present at Jefferies Healthcare Conference - TipRanks
Alpha Tau to Present at Jefferies Global Healthcare Conference - GlobeNewswire
Alpha Tau Medical Ltd. CFO Raphi Levy to Present at Jefferies Global Healthcare Conference on June 5, 2025 - Nasdaq
Alpha Tau Medical Reports Promising Q1 2025 Results - TipRanks
What is HC Wainwright’s Estimate for DRTS Q1 Earnings? - Defense World
Head to Head Review: Alpha Tau Medical (NASDAQ:DRTS) & DarioHealth (NASDAQ:DRIO) - Defense World
Alpha Tau Stock Rallies To 3-Month High On Smaller-Than-Feared Q1 Loss: Retail Sentiment Stays Bearish - MSN
Alpha Tau (DRTS) Advances Cancer Treatment Trials and Expansion Plans | DRTS Stock News - GuruFocus
Alpha Tau Medical Reports Q1 2025 Results and Major Clinical Advances - TipRanks
Alpha Tau reports Q1 EPS (12c), consensus (13c) - TipRanks
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Alpha Tau Medical (NASDAQ:DRTSW) Shares Down 0.4% – Should You Sell? - Defense World
Alpha Tau Medical (DRTS) Projected to Post Earnings on Monday - Defense World
Radiopharmaceuticals Market Products and Applications Report 2025 | SPECT Radiopharmaceuticals Lead Diagnostic Market with 67% Share - GlobeNewswire Inc.
Alpha Tau Medical sets annual meeting for June 17 By Investing.com - Investing.com Nigeria
Alpha Tau Medical Schedules Annual Shareholder Meeting for June 2025 - TipRanks
Alpha Tau Medical sets annual meeting for June 17 - Investing.com
Alpha Tau Medical appoints new board member By Investing.com - Investing.com India
Alpha Tau Appoints Nadav Kidron to Board Following Strategic Investment - TipRanks
Alpha Tau Medical appoints new board member - Investing.com Australia
Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors - GlobeNewswire
Alpha Tau Medical And 2 Other Penny Stocks Worth Your Attention - Yahoo
Renaissance Technologies LLC Has $127,000 Position in Alpha Tau Medical Ltd. (NASDAQ:DRTS) - Defense World
Femasys (NASDAQ:FEMY) & Alpha Tau Medical (NASDAQ:DRTS) Critical Comparison - Defense World
Alpha Tau Medical Announces Participation in May 2025 Investor Conferences - TipRanks
Alpha Tau to Participate in May Investor Conferences - GlobeNewswire
Alpha Tau Reveals Next-Gen Cancer Treatment Updates: CFO Set for Two Exclusive Investor Events - Stock Titan
Alpha Tau Medical’s (DRTS) Buy Rating Reiterated at HC Wainwright - Defense World
HC Wainwright Lifts Earnings Estimates for Alpha Tau Medical - Defense World
Latham & Watkins Advises Alpha Tau Medical in US$36.9 Million Registered Direct Offering - Latham & Watkins LLP
Alpha Tau Medical Ltd: Strategic Investment and Promising Clinical Milestones Drive Buy Rating - TipRanks
Oramed Invests $36.9 Million In Alpha Tau For Strategic Growth - Finimize
Alpha Tau Medical (DRTS) Secures $36.9M in Direct Offering with Oramed Pharmaceuticals | DRTS Stock News - GuruFocus
Oramed invests $36.9 million in Alpha Tau cancer therapy By Investing.com - Investing.com
Alpha Tau Medical (DRTS) Secures $36.9M in Strategic Stock Sale - GuruFocus
Oramed Invests in Alpha Tau (DRTS) with Strategic Partnership | - GuruFocus
Alpha Tau Closes $36.9 Mln Offering And Forms Strategic Alliance With Oramed Pharmaceuticals - Nasdaq
Oramed Completes $36.9 Million Strategic Investment in Alpha Tau Medical - marketscreener.com
Alpha Tau enters strategic marketing alliance with Oramed - TipRanks
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals - The Manila Times
Alpha Tau Announces Closing of $36.9 Million Registered - GlobeNewswire
Major Biotech Deal: Alpha Tau Medical Secures $36.9M Investment to Accelerate Cancer Treatment Innovation - Stock Titan
Oramed Closes $36.9M Strategic Investment in Alpha Tau Medical - citybiz
Alpha Tau Medical (NASDAQ:DRTSW) Shares Up 2.3% – Still a Buy? - Defense World
Comparing ICU Medical (NASDAQ:ICUI) and Alpha Tau Medical (NASDAQ:DRTS) - Defense World
Alpha Tau Medical Ltd Stock (DRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.38%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):